Health

Nick Pappas becomes managing director at GEHA Ventures after advising the unit for over a year.

Christine Brennan, formerly at Novartis and MSD, is returning to corporate VC at Johnson & Johnson's JJDC unit, replacing Marian Nakada.

The $250bn exit spiked February's deal numbers upwards, heading a raft of deals that took IT exit numbers to their highest point in years.

When portfolio companies start talking to each other, value compounds faster than capital.

Large exits for AI companies pushed up investor returns in January, but sub-billion-dollar IPOs are on the rise as well.

Gubra Ventures will be headed by Zoë Johnson, a former founder and biotech researcher.

January 2026 was marked by large fundraising rounds and the launch of several healthcare funds.

Emma Johnson moves from an investment role at British Business Bank to be a part of the biotech investment team at M Ventures.

After working at two pharma CVCs, Hamzeh Abdul Hadi has joined Angelini Ventures as a health tech investor in Dubai.

The new corporate venture fund will be led by Sanjeev Gupta, chief information and transformation officer at HBF Health.

With more than $37bn invested across 444 deals, January 2026 saw corporates deploy more venture money than in almost any month in the past two years.